Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Aptorum Group Ltd
About APM
Aptorum Group Limited is a United Kingdom-based clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The Company's pipeline is also enriched through the co-development of PathsDx Test, a molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, the commercialization arm of the Singapore's Agency for Science, Technology and Research.
Find out what a historical investment in Aptorum Group Ltd would be worth today using our APM stock calculator.
Market Capitalisation
$6.71M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
79
High today
$0.91
Low today
$0.81
Open price
$0.00
52-week high
$4.47
52-week low
$0.65
Ready to start your investing journey with Stake?
Open an accountHow do I buy APM shares in Australia?
Buying APM shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Aptorum Group Ltd in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in APM
What is the ticker symbol of Aptorum Group Ltd?
The ticker symbol for Aptorum Group Ltd is APM.
How much is one share of APM?
One share of APM is valued at $0.86 as of 18 May 2026.
What is the market capitalisation of Aptorum Group Ltd APM?
As of 18 May 2026 Aptorum Group Ltd has a market cap of $6.71M.
What is the 52-week high for Aptorum Group Ltd stock?
The Aptorum Group Ltd 52-week high stock price is $4.47.
What is the 52-week low for Aptorum Group Ltd stock?
The Aptorum Group Ltd 52-week low stock price is $0.65.
Can I buy APM shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy APM shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in APM on Stake
- Buy APM from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of APM from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
APM related stocks